Ambulatory insulin infusion administration unit/remote control system - Ambulatory insulin infusion administration unit/remote control system
Country: Australia
Language: English
Source: Department of Health (Therapeutic Goods Administration)
Public Assessment Report
(PAR)
23-10-2020
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Available from:
INSULET AUSTRALIA PTY LTD
Class:
Class IIb
Manufactured by:
Insulet Corporation 100 Nagog Park, Acton Massachusetts, USA, 01720 United States Of America
Therapeutic area:
63866 - Ambulatory insulin infusion administration unit/remote control system
Therapeutic indications:
An assembly of devices intended to provide continuous remotely-controlled basal and/or periodic bolus subcutaneous delivery of insulin for the management of diabetes mellitus.
Authorization status:
A
Authorization date:
2020-09-24
